Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

Name: Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study
Creator: Kevin Severson
Published: 2021-01-19T13:11:06.146Z
Keywords: Dermatology, Clinical Trial, Photodynamic Therapy, Cutaneous T-Cell Lymphoma, Mycosis Fungoides

Severson, Kevin; Cumsky, Helen; Brumfiel, Caitlin; Janeczek, Monica; Ginos, Brenda; Kosiorek, Heidi; Besch-Stokes, Jake; Patel, Meera; Rule, William; DiCaudo, David; Rosenthal, Allison; Pittelkow, Mark; Mangold, Aaron

doi:10.17632/53kf4k8266.1

Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

Published: 19 January 2021| Version 1 | DOI: 10.17632/53kf4k8266.1

Contributors:

Kevin Severson, Helen Cumsky, Caitlin Brumfiel, Monica Janeczek, Brenda Ginos, Heidi Kosiorek, Jake Besch-Stokes, Meera Patel, William Rule, David DiCaudo, Allison Rosenthal, Mark Pittelkow, Aaron Mangold

Description

Supplementary Materials for "Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study"

Files

Institutions

Mayo Clinic Arizona

Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

Description

Files

Institutions

Categories

Licence